2-(2,6-Dioxopiperidin-3-yl)-5-(piperazin-1-yl)isoindoline-1,3-dione dihydrochloride, 1g

1-TERT-BUTYL 3-METHYL 3-FLUOROPIPERIDINE-1,3-DICARBOXYLATE, 95.0%, 250mg

5-bromo-N-(4-methoxyphenyl)-2-furamide, 95.0%, 5g

2-Amino-3-bromo-5-methylpyridine>98.0%(GC)25g

2-Amino-5-(4-bromophenyl)-1,3,4-thiadiazole, 96.0%, 1g

Chlorhydrate de glycinamide, min 95 %, pour la biochimie, 25 g, emballage plastique.

[S(R)]-N-[(R)-[3,5-Di-tert-butyl-4-methoxyphenyl][5-(diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl]methyl]-2-methyl-2-propanesulfinamide, 95%, 25mg

8-FLUORO-2,3-DIHYDRO-4H-THIOCHROMEN-4-ONE, 95%, 1g

6-Bromo-7-methoxy-2-methylquinazolin-4(3H)-one, 97.0%, 1g

2,2-Difluoro-2-(1-methyl-1h-imidazol-2-yl)acetic acid, 95%, 5g

14-carboxy-1-(diazyn-1-ium-1-yl)-4,7,10,13-tetraoxa-1-azatetradecan-1-ide, 98%, 100mg

tert-Butyl (R)-3-oxohexahydroimidazo[1,5-a]pyrazine-7(1H)-carboxylate, 98%, 500mg

4-(1-Hydroxypropyl)-2-methoxyphenol, 5g